Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy

Angela Hwang is Director at UPS. OQRO lists 1 transaction filed with the SEC under this name, the latest on May 8, 2026, each linked to the official Form 4.
Director
Photo: World Economic Forum, CC BY 3.0. Original file
Disclosures on record
1
Companies involved
1
May 7, 20261,948disclosed May 8
DetailsOfficial recordAngela Hwang has no open-market purchase on record since 2021. Sales in 1 of the 6 years since 2021.
Angela Hwang reported 0 open-market purchases and 4 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2021 | — | $1.3M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Angela Hwang has no open-market purchase on record since 2021. Sales in 1 of the 6 years since 2021.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2021.
Pfizer (PFE), from 2021 to 2021: 0 purchases and 4 sales.
Angela Hwang reported 0 open-market purchases and 4 sales here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.